Tower Research Capital (TRC)’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $182K | Buy |
6,982
+4,288
| +159% | +$111K | ﹤0.01% | 1867 |
|
2025
Q1 | $66K | Sell |
2,694
-6,171
| -70% | -$151K | ﹤0.01% | 2026 |
|
2024
Q4 | $254K | Buy |
8,865
+8,541
| +2,636% | +$245K | 0.01% | 1551 |
|
2024
Q3 | $12.2K | Sell |
324
-4,803
| -94% | -$181K | ﹤0.01% | 3610 |
|
2024
Q2 | $162K | Buy |
5,127
+5,089
| +13,392% | +$161K | ﹤0.01% | 2231 |
|
2024
Q1 | $1.67K | Buy |
+38
| New | +$1.67K | ﹤0.01% | 5211 |
|